Schall, Brown & Schwartz LLP reminded investors of an ongoing class action against Capricor Therapeutics (CAPR) alleging securities-law violations under §§10(b) and 20(a). The notice itself provides no new financial metrics or outcomes, but it reinforces litigation overhang that can weigh on sentiment and the stock.
Schall, Brown & Schwartz LLP reminded investors of an ongoing class action against Capricor Therapeutics (CAPR) alleging securities-law violations under §§10(b) and 20(a). The notice itself provides no new financial metrics or outcomes, but it reinforces litigation overhang that can weigh on sentiment and the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
